title: Angiotensin and converting enzyme regulate extrarenal salt excretion in ducks.
abstract: Numerous previous studies have proposed a salt-conserving role for the renin-angiotensin system in mammals, but there is little evidence of this putative role in birds. Especially interesting are marine birds, which have a relatively limited ability to regulate the osmolality and ionic composition of their urine but possess extrarenal salt glands capable of excreting a highly concentrated NaCl solution. In the present experiments, hypertonic saline, angiotensin I (ANG I), and captopril were infused iv into chronically cannulated ducks to study the neuroendocrine, cardiovascular, renal, and extrarenal excretory responses to osmotic stress. Infusion of hypertonic saline elicited nasal salt excretion, which could be stopped completely by coadministration of ANG I. The effective dose of ANG I increased the plasma norepinephrine (NE) concentration, but did not alter heart rate or arterial blood pressure. Captopril enhanced extrarenal salt excretion in the saline-loaded ducks. The converting enzyme inhibitor also blocked the noradrenergic and NaCl-retaining actions of ANG I; conversely, coadministration of captopril and ANG I increased the plasma epinephrine (E) concentration. These findings indicate that the renin-angiotensin system, in addition to effects on the sympathoadrenal system, regulates NaCl and water metabolism in birds with extrarenal salt glands.
authors.forename: J X
authors.initials: JX
authors.lastname: Wilson
authors.forename: D V
authors.initials: DV
authors.lastname: Pham
authors.forename: H I
authors.initials: HI
authors.lastname: Tan-Wilson
mesh_terms: D000803:Angiotensin I / Q000494:pharmacology*; D000806:Angiotensin-Converting Enzyme Inhibitors; D000809:Angiotensins / Q000494:pharmacology*; D000818:Animals; D001769:Blood; D001794:Blood Pressure / Q000187:drug effects; D002216:Captopril / Q000494:pharmacology; D004231:Diuresis / Q000187:drug effects; D004298:Dopamine / Q000097:blood; D004372:Ducks / Q000502:physiology*; D004837:Epinephrine / Q000097:blood; D006982:Hypertonic Solutions; D009297:Nasal Mucosa / Q000187:drug effects / Q000378:metabolism; D009638:Norepinephrine / Q000097:blood; D009994:Osmolar Concentration; D007703:Peptidyl-Dipeptidase A / Q000502:physiology*; D012491:Salt Gland / Q000187:drug effects / Q000378:metabolism; D012965:Sodium Chloride / Q000378:metabolism* / Q000494:pharmacology
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D000809:Angiotensins; D006982:Hypertonic Solutions; D012965:Sodium Chloride; D000803:Angiotensin I; D002216:Captopril; D007703:Peptidyl-Dipeptidase A; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine